Hepion Pharmaceuticals, Inc.
HEPA
$0.06
$0.00-1.54%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -472.50K | -1.04M | -6.11M | -1.55M | -4.87M |
| Total Depreciation and Amortization | -- | -- | -- | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | 794.20K | 474.60K |
| Total Other Non-Cash Items | -47.30K | -295.30K | 4.82M | -444.00K | -38.30K |
| Change in Net Operating Assets | 73.80K | -37.50K | 167.20K | 44.30K | 1.91M |
| Cash from Operations | -446.00K | -1.38M | -1.12M | -1.15M | -2.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -132.10K | -- | 0.00 | -600.00K |
| Cash from Investing | 0.00 | -132.10K | -- | 0.00 | -600.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -157.40K | -154.50K | -2.90M | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 9.00M | 0.00 | 2.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -802.60K | -- | -- |
| Cash from Financing | -157.40K | -154.50K | 5.30M | 0.00 | 2.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 62.20K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -603.30K | -1.66M | 4.18M | -1.09M | -617.90K |